Critical insights to COVID-19 disease and potential treatments using a systems analysis approach that integrates physiology, pharmacology, and clinical pharmacology

Files

9916608950401831.pdf (273.17 KB)
  (Published version)

Date

2022

Authors

Martin, J.H.
Head, R.J.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Pharmacology Research & Perspectives, 2022; 10(1, article no. e00918):1-3

Statement of Responsibility

Conference Name

Abstract

The power of pharmacology and its application by way of clinical pharmacology to provide invaluable insights into COVID-19 disease is brought home vividly when exploring the infectivity and pathophysiology of SARS-COV-2 in this pandemic. At its core, pharmacology utilizes and displays systems analysis to identify and correct aberrant physiology in disease or to provide much needed bridging intervention in a crisis. Pharmacology describes the impact of exogenous molecules upon living systems and to achieve this the discipline has over decades developed sophisticated measures to monitor absorption, distribution, excretion, and kinetics of interaction with the principal influenced tissues and receptors.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

Copyright 2022 The authors. This is an open access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/)

License

Grant ID

Call number

Persistent link to this record